PHILIPPINE STAR/MICHAEL VARCAS
As part of a science-driven industry, the biopharmaceutical industry is leading the way in developing treatments, vaccines, and diagnostics for coronavirus disease 2019 (COVID-19). Our scientists are searching for potentially useful assets that can help with the development of new or repurposed treatments or vaccines to fight against the novel coronavirus. We are leveraging our manufacturing technologies to allow the rapid upscaling of production once a medicine or vaccine candidate is identified to meet the needs of the most affected populations. Phase 3 clinical trials are being conducted to establish safety and efficacy. We are collaborating with governments, global health and research organizations, and pharmaceutical laboratories to share knowledge, libraries, and technologies.
December 23, 2020 | 12:33 am Font Size
AAA
BOXES containing the Pfizer-BioNTech COVID-19 vaccines are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Michigan, Dec. 13. POOL VIA REUTERS
By
Senior Reporter
YASMIRA P. MONER, a 34-year-old resident of Linamon town, Lanao del Norte in southern Philippines, is eager to get a coronavirus vaccine shot because of the hassle she has to go through every time she comes home from Iligan City, where she works as a university lecturer.
“I have to queue at the local health office to get a medical certificate,” she said by telephone. “Before that, I also need to get a village clearance. I’m worried that I might get the virus there.”